Paper · 29972784

Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes.

Xu L and 11 others. Cell Rep, 2018. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes. Papers, record 29972784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29972784

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes.; PubMed
Journal: Cell Rep; PubMed
Year: 2018; PubMed
Publication types: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/29972784/; PubMed
DOI: https://doi.org/10.1016/j.celrep.2018.06.006; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC7293769/; PubMed
The journal: https://conductscience.org/library/journal-index/101573691; PubMed
Citations, by iCite: 24; iCite
Relative citation ratio, by iCite: 0.75; iCite
Revised in PubMed: 2021-01-09; PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Xu L	Lin
2	Zheng Y	Yanbin
3	Liu J	Jing
4	Rakheja D	Dinesh
5	Singleterry S	Sydney
6	Laetsch TW	Theodore W
7	Shern JF	Jack F
8	Khan J	Javed
9	Triche TJ	Timothy J
10	Hawkins DS	Douglas S

1 to 10 of 12Source PubMed

See all 12 authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Genes, Neoplasm	Major topic
Rhabdomyosarcoma	Major topic
Bayes Theorem
CRISPR-Cas Systems
Cell Differentiation
Cell Line, Tumor
DNA Copy Number Variations
Gene Expression Regulation, Neoplastic
Genes, Tumor Suppressor
Humans
Muscles
Oncogenes
Polymorphism, Single Nucleotide
RNA, Small Interfering
Survival Analysis

Source PubMed

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
P30 CA142543	NCI NIH HHS	United States	P30CA142543	PubMed and NIH	NIH RePORTER
U10 CA098413	NCI NIH HHS	United States	U10CA098413	PubMed	NIH RePORTER
U10 CA098543	NCI NIH HHS	United States	U10CA098543	PubMed	NIH RePORTER
			ZIABC011002	NIH	NIH RePORTER
			ZIABC011722	NIH	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	17,350,164	PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN.	Cancer Lett	2007	https://conductscience.org/library/papers/17350164	PubMed
2	15,466,486	A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation.	Genes Dev	2004	https://conductscience.org/library/papers/15466486	PubMed
3	24,124,571	Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).	PLoS One	2013	https://conductscience.org/library/papers/24124571	PubMed
4	17,850,214	The selectivity of protein kinase inhibitors: a further update.	Biochem J	2007	https://conductscience.org/library/papers/17850214	PubMed
5	29,100,075	Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.	Cell	2017	https://conductscience.org/library/papers/29100075	PubMed
6	10,409,765	NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.	Mol Cell Biol	1999	https://conductscience.org/library/papers/10409765	PubMed
7	20,663,909	Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer.	Cancer Res	2010	https://conductscience.org/library/papers/20663909	PubMed
8	22,774,788	Bayesian estimation supersedes the t test.	J Exp Psychol Gen	2013	https://conductscience.org/library/papers/22774788	PubMed
9	27,260,157	CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.	Cancer Discov	2016	https://conductscience.org/library/papers/27260157	PubMed
10	26,138,366	Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.	Nat Commun	2015	https://conductscience.org/library/papers/26138366	PubMed

1 to 10 of 50

See all 50 references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMID	Title	Journal	Year	In Papers	Source
42,512,121	Reannotation of Public Transcriptomic Data Identifies Candidate lncRNAs and Putative Regulatory Networks in Rhabdomyosarcoma.	Biomedicines	2026	https://conductscience.org/library/papers/42512121	PubMed
42,272,085	A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma.	Clin Transl Sci	2026	https://conductscience.org/library/papers/42272085	PubMed
41,278,839	REST elevation-dependent chromatin remodeling and alternative Grk6 transcript synthesis hyperactivates Cxcr4-Sdf1 signaling in cerebellar granule cell progenitors.	bioRxiv	2025	https://conductscience.org/library/papers/41278839	PubMed
40,996,886	Transdifferentiation of endothelial progenitor cells into rhabdomyosarcoma defined by hedgehog signaling competence.	Cell Rep	2025	https://conductscience.org/library/papers/40996886	PubMed
37,345,125	The MYC-YBX1 Circuit in Maintaining Stem-like Vincristine-Resistant Cells in Rhabdomyosarcoma.	Cancers (Basel)	2023	https://conductscience.org/library/papers/37345125	PubMed
37,115,930	TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma.	Sci Adv	2023	https://conductscience.org/library/papers/37115930	PubMed
36,941,772	Methyltransferase Inhibition Enables Tgfβ Driven Induction of CDKN2A and B in Cancer Cells.	Mol Cell Biol	2023	https://conductscience.org/library/papers/36941772	PubMed
36,830,628	Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers.	Biomolecules	2023	https://conductscience.org/library/papers/36830628	PubMed
36,793,601	Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining.	Front Oncol	2023	https://conductscience.org/library/papers/36793601	PubMed
36,376,321	Replication collisions induced by de-repressed S-phase transcription are connected with malignant transformation of adult stem cells.	Nat Commun	2022	https://conductscience.org/library/papers/36376321	PubMed

1 to 10 of 21

See all 21 cited by

Genes35

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
CCND1	595	PubTator's text mining	https://conductscience.org/library/genes/595	NCBI Gene
CDKN1A	1,026	PubTator's text mining	https://conductscience.org/library/genes/1026	NCBI Gene
CDKN2A	1,029	PubTator's text mining	https://conductscience.org/library/genes/1029	NCBI Gene
CKM	1,158	PubTator's text mining	https://conductscience.org/library/genes/1158	NCBI Gene
E2F5	1,875	PubTator's text mining	https://conductscience.org/library/genes/1875	NCBI Gene
ETV1	2,115	PubTator's text mining	https://conductscience.org/library/genes/2115	NCBI Gene
EZH2	2,146	PubTator's text mining	https://conductscience.org/library/genes/2146	NCBI Gene
FGFR4	2,264	PubTator's text mining	https://conductscience.org/library/genes/2264	NCBI Gene
FOXO1	2,308	PubTator's text mining	https://conductscience.org/library/genes/2308	NCBI Gene
GLI2	2,736	PubTator's text mining	https://conductscience.org/library/genes/2736	NCBI Gene

1 to 10 of 35

See all 35 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29972784

GET https://conductscience.org/api/papers/v1/29972784/references?page=2

API reference For AI assistants